PharmaVoice’s Post

We are thrilled to share that we will be proudly serving as a Sponsor at the forthcoming 14th Edition Vaccine world summit 2024. Our commitment to advancing clinical research is unwavering, and we look forward to engaging with professionals in the field. Visit us at Booth No. 05 to discuss how our clinical trial services can contribute to the success and growth of your vaccine and biosimilar clinical development programme. #clinicalresearch #clinicaldatamanagement #abiogenesisclinpharm #vaccines #biosimilars #biostatistics #medicaldevices #medicalaffairs

Thoughts on this? >> NIH sends BioNTech 'notice of default' over Covid vaccine royalties >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #pharma #productmarketing #biotech

Thoughts on this? >> AstraZeneca pulls Covid-19 vaccine globally as the pharma sees 'no future commercial demand' >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharmaceutical #productmarketing #pharma

#News: Physicians are unequivocal about who is the big kahuna in the vaccine industry. Asked to rank #vaccinemanufacturers on five metrics, physicians produced a leaderboard that reads Pfizer, yawning gap, #Merck. ZOOMRX generated the ranking by asking 50 physicians to name the top vaccine manufacturers in five areas: reputation, innovation, patient centricity, promotions and HCP centricity. The doctors ranked 13 vaccine manufacturers, but the same name kept appearing toward the top of their lists, regardless of the metric being assessed. Around 80% of respondents ranked Pfizer as one of the top three companies in every category. Merck came closest to keeping pace with Pfizer but was still a long way back. The closest Merck got to Pfizer was in the innovation and patient centricity categories, where the front-runner had a 23 percentage point lead over second place. “Pfizer leads by a huge margin across all metrics,” ZoomRx wrote in its assessment of the results. “Their quick response to the pandemic with the COVID-19 vaccine is still holding high regards and recognition.” Read more from Fierce Pharma 👇🏼

Optimising a freeze-drying process to improve the long-term stability of lyophilised mRNA-LNPs: in their latest article, Teresa Alejo, Diego de Miguel at Certest Biotec, S.L. and collaborators aimed to optimise a lyophilisable mRNA-LNP formulation by carefully selecting the best buffer and cryoprotectant and fine-tuning freeze-drying parameters https://lnkd.in/e9EX2nfE Their findings showed that the optimized lyophilisation process preserved LNP characteristics and functionality for over a year at refrigerated temperatures, providing a practical solution to the logistical challenges of mRNA vaccine distribution. An article co-authored by Alfonso Toro Córdova, Lara Berdiel Fernández, Andrea Rivero Gallegos, Andrei Mihai Stoian, Luna Pérez, Victor Navarro Bernad and Juan Martínez Oliván #LNPs #vaccines #mRNA #lyophilisation #thermostability #cryoTEM #Vesiculab

Thoughts on this? >> HilleVax's stock tumbles after Phase 2b norovirus vaccine fails in infants >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #productmarketing #pharma #healthcare #biotech

Physicians are on board with mRNA vaccines, but worry about patient misinformation, survey finds >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #healthcare #pharma #productmarketing

Thoughts on this? >> HilleVax's stock tumbles after Phase 2b norovirus vaccine fails in infants >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #productmarketing #pharmaceutical #pharma

Prima RNApols™ are compatible with any DNA template sequence and length, facilitating the manufacturability of long mRNAs (>10 kb) for self-amplifying mRNA-based drugs, and achieving higher yields per DNA template unit. Work with us: https://bit.ly/3XTud85 #PrimroseBio #PrimaRNApols #mRNA #vaccines #therapeutics

Thoughts on this? >> Vaxcyte's 'stunning' 31-valent pneumococcal vaccine win against Pfizer's Prevnar 20 has analysts thinking big >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #competitivemarketing #healthcare #pharma